Total Payments
$6,737
2024 Payments
$1,837
Companies
24
Transactions
144
Medicare Patients
268
Medicare Billing
$43,576
Payment Breakdown by Category
Food & Beverage$4,459 (66.2%)
Travel$2,200 (32.7%)
Education$77.63 (1.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,459 | 121 | 66.2% |
| Travel and Lodging | $2,200 | 22 | 32.7% |
| Education | $77.63 | 1 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic, Inc. | $4,139 | 52 | $0 (2024) |
| Abbott Laboratories | $395.39 | 5 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $297.38 | 16 | $0 (2024) |
| Cardiovascular Systems Inc. | $282.14 | 4 | $0 (2023) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $259.84 | 16 | $0 (2024) |
| Chiesi USA, Inc. | $195.63 | 5 | $0 (2024) |
| Boston Scientific Corporation | $177.86 | 2 | $0 (2022) |
| Actelion Pharmaceuticals US, Inc. | $109.88 | 4 | $0 (2024) |
| Novo Nordisk Inc | $109.65 | 5 | $0 (2024) |
| ATRICURE, INC. | $95.47 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,837 | 50 | Medtronic, Inc. ($1,172) |
| 2023 | $1,189 | 42 | Medtronic, Inc. ($326.08) |
| 2022 | $3,224 | 44 | Medtronic, Inc. ($2,626) |
| 2021 | $435.68 | 5 | BOSTON SCIENTIFIC CORPORATION ($149.84) |
| 2020 | $39.43 | 2 | Medtronic Vascular, Inc. ($39.43) |
| 2018 | $11.36 | 1 | Medtronic Vascular, Inc. ($11.36) |
All Payment Transactions
144 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $34.71 | General |
| Category: Renal Denervation System | ||||||
| 12/12/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: Genetic Disease | ||||||
| 12/06/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $47.84 | General |
| Category: Cardiology | ||||||
| 11/26/2024 | Chiesi USA, Inc. | KENGREAL (Drug) | Food and Beverage | Cash or cash equivalent | $16.14 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/07/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: Cardiology | ||||||
| 11/07/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $12.04 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/28/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $123.84 | General |
| Category: Renal Denervation System | ||||||
| 10/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.35 | General |
| Category: DIABETES | ||||||
| 10/09/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $25.24 | General |
| Category: Cardiology | ||||||
| 09/19/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Obesity | ||||||
| 09/09/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $21.14 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 08/16/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Cardiology | ||||||
| 08/15/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $36.43 | General |
| Category: Cardiology | ||||||
| 08/01/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $12.30 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/24/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/24/2024 | Chiesi USA, Inc. | KENGREAL (Drug) | Food and Beverage | Cash or cash equivalent | $13.84 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/11/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/28/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $12.05 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 06/26/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/03/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $11.02 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 05/10/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $25.45 | General |
| Category: Cardiology | ||||||
| 05/01/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $6.49 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 04/08/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $25.92 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/27/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $20.39 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 03/20/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $30.86 | General |
| Category: Cardiac Rhythm Management | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 207 | 244 | $122,066 | $32,370 |
| 2022 | 4 | 61 | 71 | $37,067 | $11,207 |
Total Patients
268
Total Services
315
Medicare Billing
$43,576
Procedure Codes
13
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93456 | Insertion of tube in right heart chambers and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 22 | 23 | $26,330 | $6,140 | 23.3% |
| 93454 | Insertion of tube in coronary artery for diagnosis with review by radiologist | Facility | 2023 | 29 | 29 | $25,722 | $5,530 | 21.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 23 | 34 | $13,337 | $5,146 | 38.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 36 | 46 | $13,591 | $5,007 | 36.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 20 | 20 | $9,720 | $2,727 | 28.1% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 13 | 13 | $14,104 | $2,654 | 18.8% |
| 93451 | Insertion of tube in right heart chambers for measurement | Facility | 2023 | 20 | 22 | $10,890 | $2,480 | 22.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 14 | 23 | $6,268 | $2,292 | 36.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 30 | 34 | $2,104 | $393.27 | 18.7% |
| 93454 | Insertion of tube in coronary artery for diagnosis with review by radiologist | Facility | 2022 | 16 | 16 | $14,048 | $3,318 | 23.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 11 | 16 | $9,483 | $3,051 | 32.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 16 | 16 | $7,778 | $2,777 | 35.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 18 | 23 | $5,758 | $2,061 | 35.8% |
About Dr. Nardos Temesgen, MD
Dr. Nardos Temesgen, MD is a Cardiovascular Disease healthcare provider based in Washington, District of Columbia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/28/2015. The National Provider Identifier (NPI) number assigned to this provider is 1508250424.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nardos Temesgen, MD has received a total of $6,737 in payments from pharmaceutical and medical device companies, with $1,837 received in 2024. These payments were reported across 144 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($4,459).
As a Medicare-enrolled provider, Temesgen has provided services to 268 Medicare beneficiaries, totaling 315 services with total Medicare billing of $43,576. Data is available for 2 years (2022–2023), covering 13 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology
- Location Washington, DC
- Active Since 03/28/2015
- Last Updated 05/01/2025
- Taxonomy Code 207RC0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1508250424
Products in Payments
- RESOLUTE ONYX (Device) $2,336
- ONYX FRONTIER (Device) $1,452
- Diamondback Coronary (Device) $282.14
- LifeVest (Device) $259.84
- KENGREAL (Drug) $195.63
- SYMPLICITY G3 (Device) $158.55
- ENTRESTO (Drug) $154.52
- OPTICROSS (Device) $149.84
- LEQVIO (Drug) $142.86
- COROFLOW (Device) $135.37
- AVEIR (Device) $118.16
- OPTIS (Device) $117.26
- OPSUMIT (Drug) $109.88
- EUPHORA (Device) $94.20
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) $82.28
- XARELTO (Drug) $78.92
- VERQUVO (Drug) $78.62
- Repatha (Biological) $72.36
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (Device) $57.43
- WAINUA (Drug) $53.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Washington
Dr. Toby Rogers
Cardiovascular Disease — Payments: $812,095
Cardiovascular Disease $812,095
Hayder Hashim, M.d, M.D
Cardiovascular Disease — Payments: $573,299
Cardiovascular Disease $573,299
Dr. Joshua Yamamoto, M.d, M.D
Cardiovascular Disease — Payments: $423,212
Cardiovascular Disease $423,212
Zayd Eldadah, Md, Phd, MD, PHD
Cardiovascular Disease — Payments: $379,254
Cardiovascular Disease $379,254
Mardi Gomberg-Maitland, Md, MD
Cardiovascular Disease — Payments: $305,036
Cardiovascular Disease $305,036
Jonathan Reiner, M.d, M.D
Cardiovascular Disease — Payments: $220,893
Cardiovascular Disease $220,893